AngioDynamics to Ring NASDAQ Closing Bell to Celebrate the 15th Anniversary of its Listing on the Exchange
May 28 2019 - 8:00AM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of
innovative, minimally invasive medical devices for vascular access,
peripheral vascular disease, and oncology, today announced that
representatives of the Company will ring the NASDAQ Stock Market
closing bell on Tuesday, May 28, 2019 at 4:00 p.m. ET to
commemorate the 15-year anniversary of the Company’s listing on the
exchange.
“NASDAQ has provided AngioDynamics with a robust platform to
access the public equity markets and connect with potential
shareholders and investors,” said Jim Clemmer, President and Chief
Executive Officer of AngioDynamics. “Since going public over 15
years ago, we have grown almost 10-fold in revenue and are now
driving future growth through focused, strategic choices in key
therapeutic areas. We are making targeted investments aimed at
advancing proprietary medical technologies, such as AngioVac®,
BioFlo®, and the NanoKnife® System, all of which are addressing
unmet patient needs.”
Clemmer added, “Every day, AngioDynamics’ talented and dedicated
employees leverage their expertise in R&D and manufacturing to
deliver medical technologies that support high-quality care,
wellness, and cures for people living with society’s most
challenging diseases. We believe that these patients deserve to
live healthier, happier lives, and we are making meaningful strides
across all facets of our business in support of this core belief
that we each share.”
AngioDynamics’ current fiscal year closes May 31, 2019. During
the current fiscal year, the Company completed the consolidation of
two production facilities; acquired BioSentry Tract Sealant®
technology and RadiaDyne; and announced the divestiture of its
NAMIC Fluid Management business. Additionally, the Company enrolled
the first patient in its DIRECT Clinical Study for the treatment of
Stage III pancreatic cancer and also received approval from the
United States Food and Drug Administration (FDA) to initiate a
pilot study for the use of NanoKnife in the treatment of prostate
cancer.
This afternoon, at 4:00 p.m. ET, AngioDynamics’ executive
management team will be joined by fellow team members at the NASDAQ
Stock Exchange in New York, where its three most tenured employees
will ring the closing bell on behalf of the Company. A live stream
of the bell ringing ceremony will be available at:
https://new.livestream.com/nasdaq/live.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative,
minimally invasive medical devices used by professional healthcare
providers for vascular access, peripheral vascular
disease, and oncology. AngioDynamics’ diverse product
lines include market-leading ablation systems, fluid management
systems, vascular access products, angiographic products and
accessories, drainage products, thrombolytic products and venous
products. For more information,
visit www.angiodynamics.com.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading,
clearing, exchange technology, listing, information and public
company services. Through its diverse portfolio of solutions,
Nasdaq enables customers to plan, optimize and execute their
business vision with confidence, using proven technologies that
provide transparency and insight for navigating today's global
capital markets. As the creator of the world's first electronic
stock market, its technology powers more than 100 marketplaces in
50 countries. Nasdaq is home to approximately 4,000 total listings
with a market value of approximately $14 trillion. To learn more,
visit: http://business.nasdaq.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190528005196/en/
Investor Relations Contact:AngioDynamics, Inc.Michael C.
Greiner518-795-1821mgreiner@angiodynamics.comMedia
Contact:AngioDynamics, Inc.Saleem
Cheeks518-795-1174scheeks@angiodynamics.com
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Apr 2023 to Apr 2024